Literature DB >> 29499798

Medical Management of Facial Redness in Rosacea.

Abigail Cline1, Sean P McGregor2, Steven R Feldman3.   

Abstract

Persistent centrofacial erythema is a predominant component of rosacea. The authors review the topical and systemic treatments for rosacea-related erythema and flushing to aid in treatment decision making in clinical practice. Databases were searched for literature pertaining to treatment options for erythema related to rosacea. The paucity of large-scale clinical trials in patients with the erythematotelangiectatic rosacea subtype makes it difficult to draw firm conclusions regarding treatment. Although certain topical and oral treatments appear to have modest benefit in reducing erythema, there is a need for high-quality, well-designed, and rigorously reported studies for the treatments for rosacea.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Erythema; Erythematotelangiectatic; Management; Papulopustular; Rosacea; Topical

Mesh:

Substances:

Year:  2017        PMID: 29499798     DOI: 10.1016/j.det.2017.11.010

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  3 in total

1.  Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

Authors:  James Q Del Rosso; Emil Tanghetti; Guy Webster; Linda Stein Gold; Diane Thiboutot; Richard L Gallo
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

2.  Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.

Authors:  Andres Luque; Aida Paola Rojas; Andrea Ortiz-Florez; Juliana Perez-Bernal
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

Review 3.  Light-Based Devices for the Treatment of Facial Erythema and Telangiectasia.

Authors:  Vani Yepuri; Anant D Patil; Klaus Fritz; Carmen Salavastru; George Kroumpouzos; Steven Paul Nisticò; Domenico Piccolo; Ahmed Sadek; Ashraf Badawi; Martin Kassir; Michael H Gold; Stephan Große-Büning; Stephan Grabbe; Mohamad Goldust
Journal:  Dermatol Ther (Heidelb)       Date:  2021-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.